Drug Type Small molecule drug |
Synonyms BIT314 |
Target- |
Action inhibitors |
Mechanism Hepatitis C virus replication inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis C | Preclinical | Australia | 01 Sep 2017 |





